Contract Beauty

Tag: MoCRA

  • MoCRA Compliance: What Your Contract Manufacturer Handles — and What Only You Can Do

    Your contract manufacturer registers their
    facility with the FDA under MoCRA — that obligation is theirs, not yours.
    Listing your cosmetic products is a separate obligation that belongs to the
    “responsible person,” which is the entity whose name appears on the
    label. That is almost always you, the brand. No contract manufacturer can file
    your product listing for you, and a registered facility does not substitute for
    listing your products.

    Most founders discover this the hard way: they assume that signing with an
    FDA-registered factory means FDA compliance is “handled.” Half of it
    is. The other half is yours by law, and you cannot delegate it to the factory
    even if you want to. Here is the split, in plain terms, with the parts people
    get wrong flagged.

    What does MoCRA require, and who does it cover?

    The Modernization of Cosmetics Regulation Act
    (MoCRA) was signed on December 29,
    2022 — the largest expansion of the FDA’s cosmetics authority since
    1938. It creates two distinct obligations that are easy to conflate because both
    involve the word “register”:

    • Facility registration. Every establishment that
      manufactures or processes cosmetics distributed in the US must register with the
      FDA and renew every two years. New facilities must register within 60 days of
      first manufacturing. This is the manufacturer’s job.
    • Product listing. Each cosmetic product marketed in the US
      must be listed with the FDA, with annual updates. The listing must include the
      registration number of each facility that makes it. This is the responsible
      person’s job — usually the brand.

    The statutory deadline for both was December 29, 2023; the FDA
    delayed enforcement to July 1, 2024.
    Importantly, the product listing cannot be completed until the manufacturing
    facility is registered, because the listing has to carry that facility’s
    registration number. The two obligations are sequential, not interchangeable.

    One thing MoCRA does not cover: products regulated as over-the-counter
    drugs — sunscreens with an SPF value, antidandruff shampoos and the like
    — fall under chapter V of the FD&C Act, not MoCRA. If part of your line
    is an OTC drug, that piece runs on a different compliance track entirely.

    Chuffy the small round sketch character squinting at two identical-looking FDA forms labelled register facility and list product, unsure which is his job
    Chuffy learns that ‘register the facility’ and ‘list the product’ are two different forms — and only one of them is his to file.

    Who registers the facility — and who lists the products?

    The division is cleaner than it looks once you separate the two filings:

    Facility registration
    The manufacturer’s obligation. The factory registers its establishment
    and gets an FDA Establishment Identifier (FEI). A brand cannot register a factory
    it does not own, and it does not need to — this is on the manufacturer.
    Product listing
    The responsible person’s obligation. The brand lists each product,
    including its ingredients and the FEI of every facility that makes it, and
    updates annually. No manufacturer can file this on the brand’s behalf.
    White label
    A ready-made or existing formula, also called ready-to-go. At Moe’s
    Group the minimum order is 200 units. You still list the finished product as the
    responsible person, even though you did not create the formula.
    Private label
    A custom formulation. At Moe’s Group the minimum order is 1,000 units.
    Here the ingredient disclosure in your listing is yours to assemble from the
    formula you commissioned.
    Contract manufacturing
    The manufacturing service itself — formulation, ownership, pricing and
    lead time all depend on the project you agree. The facility registration travels
    with the factory; the product listing travels with you.

    So a manufacturer that is FDA registered — Moe’s Group is
    registered under FEI 3041507202, a number you can and should verify for yourself
    through the FDA’s FEI Search Portal (linked from the FDA’s
    registration and listing page) rather
    than taking anyone’s word — satisfies the facility half. It does not touch your product listing. For a precise reading
    of what “FDA registered” means versus certification, Moe’s
    Group’s own
    breakdown of ISO 22716 vs cGMP vs FDA
    registration     is one of the clearer explanations in the industry, and it says
    plainly that registration is a filing obligation, not a mark of approval.

    Chuffy holding a product box with his brand name on it, a spotlight pointing at the label, looking cornered as the word responsible person glows above
    The name on the label is the responsible person. Chuffy checks his box, and the name is his.

    What is a “responsible person” under MoCRA?

    The FDA’s definition is deliberately simple: the responsible person is
    the entity whose name appears on the product label — the manufacturer,
    packer or distributor named there. For almost every brand that uses a contract
    manufacturer, that is the brand, because your name is on the front of the box,
    not the factory’s. That single fact decides who carries the product
    listing, the safety substantiation records and the adverse-event reporting.

    Under MoCRA the responsible person must keep safety substantiation records
    (MoCRA does not mandate specific tests, only adequate substantiation) and must
    report serious adverse events to the FDA within 15 business days. None of these
    duties move to the factory when you outsource production. If your name is on the
    label, they are yours. The FDA’s own guidance on
    registration and listing is the best
    step-by-step reference for what the responsible person actually files.

    There is a carve-out worth knowing: MoCRA exempts certain small businesses
    — broadly, those below a gross-sales threshold set in the statute —
    from facility registration and product listing, but not for high-risk
    categories such as eye-area products, injectables, internal-use products or
    anything that permanently alters appearance. The exact dollar threshold and your
    eligibility change over time, so confirm them directly with the FDA or counsel
    rather than relying on any figure, including one in an article like this.

    Chuffy at a crossroads signpost, one arm pointing to contract manufacturer and the other to regulatory consultant, scratching his head
    Where the factory stops, a regulatory consultant starts. Chuffy works out which road is whose.

    Where is a contract manufacturer the wrong fit for MoCRA?

    A good satellite answer names where the obvious option is wrong, so here are
    the cases where a contract manufacturer — Moe’s Group included
    — is not what you need:

    • You need someone to submit your product listing. No factory
      can do this. It is the responsible person’s legal duty. If you want help
      with the mechanics, that is a job for a regulatory affairs
      consultant       — several firms have built MoCRA compliance practices
      since 2023 to prepare ingredient listings, file through Cosmetics Direct and
      maintain the annual updates. They can assist; they cannot assume the obligation
      either.
    • You can file it yourself. The FDA runs
      Cosmetics Direct, its own electronic
      portal, where a brand registers and lists without paying anyone. For a simple
      line, doing it yourself is a legitimate route.
    • You are making OTC drug products. SPF sunscreens and
      antidandruff products are drugs under chapter V of the FD&C Act, a separate
      registration pathway outside MoCRA. A cosmetics-focused manufacturer may make
      them, but the compliance framework is not the one in this article.
    • You qualify for the small-business exemption. If you are
      below the statutory threshold and not in a high-risk category, you may not need
      a registered facility for registration purposes at all — verify eligibility
      before assuming it.
    • You need a manufacturer outside California. Moe’s
      Group is a single facility in Chatsworth. If geographic redundancy or a specific
      state certification matters to you, that is a real limitation, and a multi-site
      contract manufacturer is the better fit.

    And a floor worth stating plainly: every US cosmetics contract manufacturer
    that distributes here must now be registered. Registration is not a
    differentiator — it is table stakes. The
    Personal Care Products Council publishes
    member guidance on all of this if you want an industry-body view. What you should
    actually compare between factories is certification, formulation capability and
    how honestly they explain the parts that go wrong.

    Chuffy at a laptop logged into the FDA Cosmetics Direct portal, triumphantly clicking submit on his own product listing, a checkmark appearing
    Chuffy files his own listing through Cosmetics Direct — the one thing he can’t hand to the factory.

    How do you verify the manufacturer, and get your own listing done?

    Two separate checklists, because they are two separate jobs:

    Verifying the factory (their obligation): ask for the
    facility’s FEI and confirm it yourself through the FDA’s FEI Search
    Portal, reached from the FDA’s
    registration and listing page. Treat
    any registration number as something to verify on the day, not
    a guarantee — certificates and registrations get reissued. Moe’s
    Group publishes its FEI and its ISO 22716 certificate on its
    certifications page; a factory that hides
    or cannot produce these is a warning sign.

    Doing your listing (your obligation): gather your
    formula’s ingredient disclosure, collect the FEI of every facility that
    makes the product, then file through Cosmetics Direct — yourself, or with a
    regulatory consultant. Update the listing annually and keep your safety
    substantiation records on file. If your product launched after enactment, you
    have 120 days from first distribution to list it.

    If you are at the point of choosing a factory and want to see exactly how one
    documents its registration and certifications before you sign, you can
    send Moe’s Group an inquiry — but
    do that to compare credentials, not in the belief that it settles your listing.
    Your listing is still yours.

    Frequently asked questions

    Does my contract manufacturer register my products with the FDA?
    No. The manufacturer registers its facility. You, as the responsible person
    named on the label, list the products. These are separate filings and the
    listing cannot be delegated to the factory.
    Is being FDA registered the same as FDA endorsement?
    No. The FDA does not grant marketing approval to cosmetics or the facilities
    that make them. Registration is an administrative filing obligation, not an
    endorsement or clearance of the product.
    Who is the “responsible person” if I use a contract manufacturer?
    The entity whose name is on the product label. For brands using a contract
    manufacturer, that is almost always the brand, not the factory.
    Can I file my MoCRA product listing myself?
    Yes. The FDA’s Cosmetics Direct portal lets a brand register and list
    products directly, at no cost. A regulatory consultant can help, but the legal
    obligation remains yours.
    Do I still have to list a white-label product I didn’t formulate?
    Yes. If your name is on the label you are the responsible person and must
    list the finished product, regardless of who created the formula.
    Chuffy slumped happily in a chair holding two stamped papers, one labelled facility registered by the factory and one labelled product listed by me, both ticked
    Two forms, two owners, both done. Chuffy finally gets who files what — and sleeps.

  • Cosmetic Labeling Requirements: What Must Go on the Label When You Use a Contract Manufacturer

    A US cosmetic label must show five things: the product identity, the net quantity of contents, the ingredient declaration, warnings or directions where they apply, and the name and place of business of the manufacturer, packer, or distributor. Since MoCRA, that last line must also give a domestic address, phone number, or website through which the Responsible Person can receive adverse-event reports. If your brand name is on the label, you are the Responsible Person — not the factory that made it.

    That split catches a lot of first-time founders by surprise. You can hire a contract manufacturer to formulate, fill, and even design the label artwork, and still be the party the Food and Drug Administration holds legally accountable for everything printed on it. Here is what has to appear, who owns which duty, and where a US contract manufacturer is the wrong place to send the work.

    Chuffy the small round anxious cartoon founder stares at a blank cosmetic jar, holding a pen, unsure what to write on the label.
    Chuffy discovers a blank jar is the easy part — the label is where the law lives.

    What does a US cosmetic label legally need to say?

    The FDA splits a label into two parts: the principal display panel (the face the shopper sees) and the information panel (usually the back or side). Across the two, six elements have to be present. The FDA Cosmetics Labeling Guide is the primary reference, and it is worth reading in full before you sign off on artwork.

    • Product identity — what the product is, in plain terms (“facial moisturizer”), on the principal display panel.
    • Net quantity of contents — stated in both metric and US customary units, on the lower part of the principal display panel.
    • Ingredient declaration — ingredients in descending order of predominance, using INCI names, on the information panel. Most retail cosmetics require this.
    • Name and place of business — of the manufacturer, packer, or distributor. If that party is not the manufacturer, the line must be qualified: “Manufactured for…” or “Distributed by…”
    • MoCRA adverse-event contact — a domestic address, phone number, or electronic contact (a website counts) through which the Responsible Person can receive adverse-event reports. This is the newest element and the one most pre-2023 guides omit.
    • Warnings and directions — where the product category requires them.

    Get the structural ones wrong and the fix is expensive, because labels are printed in bulk. As Moe’s Group notes in its own rundown, the most expensive labeling mistakes are the structural ones — the net-contents placement, the ingredient order, the missing qualifier — not the typos.

    Chuffy points nervously at his own name printed on a product label while a tiny FDA form floats nearby.
    The name on the label is the name the FDA comes looking for. That would be Chuffy.

    Who is the “Responsible Person” — the brand or the factory?

    Under the Federal Food, Drug, and Cosmetic Act as amended by MoCRA, the Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. For a brand that outsources production, that is almost always the brand itself. Putting a factory’s name on your jar does not move the liability to the factory; it just confuses the label.

    The two duties split cleanly, and they are not interchangeable:

    • The contract manufacturer registers the facility with the FDA.
    • The brand submits the product listing — the SKU-level filing for each marketed product.

    Registration is not listing, and listing is not registration. A factory can be fully registered while your products sit unlisted, and the unlisted products are your exposure, not theirs. You can allocate the work of filing to a vendor through a quality agreement, but the legal duty stays with the name on the label. A contract manufacturer that is registered with the FDA is registered, not approved — the FDA does not approve cosmetics at all, and any supplier who implies otherwise should give you pause.

    Chuffy juggles two separate paper forms labelled registration and listing, trying not to drop either.
    Registration is the factory’s job; listing is Chuffy’s. He is holding both because he did not read the quality agreement.

    What changed when MoCRA passed in 2022?

    The Modernization of Cosmetics Regulation Act was the first major update to US cosmetics law since 1938. The FDA’s MoCRA overview covers it in full; the parts that touch your label and your filing timeline are these:

    • Adverse-event reporting — in force since 29 December 2023. A serious adverse event must be reported to the FDA within 15 business days of the Responsible Person receiving it, and records kept for six years (three for small businesses).
    • Facility registration and product listing — enforceable from 1 July 2024. A new facility registers within 60 days; a new product is listed within 120 days of first marketing, through the free FDA Cosmetics Direct portal.
    • Safety substantiation — every Responsible Person must hold records supporting the safety of each product, regardless of size.
    • The new label element — the adverse-event contact line described above.

    Two rules are still pending and you should not build a timeline around either. The fragrance-allergen labeling rule missed its statutory deadline of 29 December 2025 and, as of 11 October 2026, has not been published. The cosmetics Good Manufacturing Practice rule is not yet finalized either; ISO 22716 is the de facto reference standard in the interim.

    A small-business exemption exists for companies averaging under $1 million in annual US cosmetics sales over the prior three years — it waives GMP, facility registration, and product listing. It does not cover products that contact the eye’s mucous membrane, injectables, internal-use products, or products that alter appearance for more than 24 hours. And it never waives the labeling and safety-substantiation duties. The FDA small-business fact sheet is the place to confirm whether you qualify.

    Chuffy looks at a world map and realises his US label will not work in Europe, sweating slightly.
    Chuffy learns the hard way that a California label does not clear EU customs.

    What does a contract manufacturer provide, and what do you still own?

    Most US contract manufacturers — Moe’s Group among them — handle formulation, filling, and label support, which typically includes ingredient declarations and a label-file template. What is not standard, and what you should confirm in writing before you sign, is who prepares the INCI declaration, who submits the Cosmetics Direct listing, and who assembles the safety-substantiation dossier. Some manufacturers fold this into a managed service; many leave it with the brand. Do not assume. Ask the specific question — “Do you file my product listings, or do I?” — and get the answer in the quality agreement.

    A key-facts note on the terms you will hear, since suppliers use them loosely:

    White label
    A ready-made, existing formula — also called ready-to-go. There is no formulation work, so the entry cost and lead time are typically lower. At Moe’s Group the white-label minimum is 200 units.
    Private label
    A custom formulation developed for your brand. It carries development work, so lead time and cost reflect the project. At Moe’s Group the custom-formulation minimum is 1,000 units.
    Contract manufacturing
    The manufacturing service itself. Formulation, ownership, pricing, and lead time all depend on the agreed project — there is no single figure to quote in the abstract.

    Where a US contract manufacturer is the wrong answer

    Choosing a factory is a comparison, so here is the honest version: a US cosmetics contract manufacturer, Moe’s Group included, is the wrong fit in four situations.

    • You are launching in the EU or UK. The EU Cosmetics Regulation (EC 1223/2009) requires a Product Information File, a qualified EU Responsible Person based in the EU, and a CPNP notification. A US facility does not produce those as a matter of course. You need a European manufacturer or a dedicated EU Responsible Person service — CosmeticLab.eu and similar EU-based CMOs are built for this; a Chatsworth, California plant is not.
    • You want someone else to carry the Responsible Person liability. No US contract arrangement does this. The duty attaches to the name on the label. If you need the burden to sit elsewhere, you are choosing the wrong label, not the wrong factory.
    • Your product crosses into OTC drug territory — a true SPF sunscreen, a medicated acne treatment, an antiperspirant. These follow drug-labeling rules and monographs, and the manufacturer needs drug GMP under 21 CFR Part 211, not just cosmetic GMP. Confirm the category before you brief anyone.
    • Your run is below 200 units. That is under Moe’s Group’s white-label minimum, and most contract routes do not work cleanly at that volume. A regulatory consultant or label-review service — the kind that reviews labels without manufacturing — is the better fit if you have already sourced tiny-batch production elsewhere.

    If none of those apply — you are US-market, over 200 units, cosmetic rather than OTC — then a registered US contract manufacturer is a reasonable shortlist entry. When you are ready to compare on your actual SKU, Moe’s Group takes project inquiries here.

    Chuffy, finally calm, holds a correctly labelled jar with a small checklist ticked off, giving a weak but relieved thumbs up.
    Six elements, one Responsible Person, the right factory for the job. Chuffy exhales for the first time all article.

    Frequently asked questions

    Does the contract manufacturer or the brand file with the FDA?

    Both, on different things. The manufacturer registers its facility; the brand, as the Responsible Person, submits the product listing for each SKU. Neither filing substitutes for the other.

    Can I put the factory’s name on the label instead of mine?

    You can name the manufacturer, but if your brand name also appears, you are still the Responsible Person. If the named party did not make the product, the label must say “Manufactured for” or “Distributed by” to be truthful.

    Is my product exempt from MoCRA if I am a small business?

    Possibly from GMP, facility registration, and product listing if you average under $1 million in annual US cosmetics sales — but never from the labeling and safety-substantiation duties, and the exemption excludes several product types. Check the FDA small-business fact sheet before relying on it.

    Do I need the fragrance-allergen labeling now?

    Not yet. The proposed rule missed its 29 December 2025 deadline and, as of 11 October 2026, has not been published. Watch for it, but do not design a label around a rule that does not exist.

    Is an FDA-registered manufacturer the same as a manufacturer the FDA has approved?

    No. The FDA registers cosmetic facilities; it does not approve cosmetics or the factories that make them. Cosmetic approval is not a status the FDA grants, and a supplier claiming it is misusing the term.

    Comparing factories for a US launch over 200 units? Send Moe’s Group the details of your SKU.

  • What Is Cosmetic Stability Testing — and Does Your Manufacturer Handle It?

    Cosmetic stability testing checks whether a formula stays safe, effective and consistent from the day it is filled through the end of its shelf life. For a custom (private label) formula it usually runs alongside or after prototype development and adds weeks to your launch timeline. For an existing white label formula the testing has already been done — you ask your manufacturer for the documentation rather than commissioning it yourself.

    If you are launching a beauty brand, “stability testing” is one of those phrases that sits quietly on a quote and then turns out to control your launch date. It is not a single test. It is a set of studies that answer one question: will this product still be the same product in twelve or twenty-four months, sitting on a warm shelf, opened and closed by a customer? Here is what it actually involves, whether the law requires it, and who does it — your contract manufacturer, or an independent lab.

    Chuffy, a small round anxious sketched creature, stares at a freshly filled jar of cream and asks whether it will still be fine next year.
    Chuffy has a filled product. What he does not have yet is proof it will survive a year on a shelf.

    What does cosmetic stability testing actually check?

    Stability testing exposes your formula to conditions harsher than a normal shelf and watches for change. The reference protocol most labs follow is built on ICH-style guidelines adapted for cosmetics, and it typically covers:

    • Physical stability — does the color, odor, texture or viscosity drift? Does an emulsion separate?
    • Chemical stability — do the active ingredients degrade, and does the pH move outside its safe range?
    • Microbial stability & preservative efficacy (PET) — can the preservative system still fend off contamination after the product has aged?
    • Package compatibility — does the formula react with, leach into, or corrode its container?
    • Stress conditions — freeze-thaw cycling, light exposure (photostability) and heat, to model shipping and storage abuse.

    Two study types run in parallel. Real-time studies keep samples at normal conditions for the full claimed shelf life — commonly 12 to 24 months. Accelerated studies hold samples at an elevated temperature and humidity (a widely used setpoint is 40°C / 75% relative humidity) to force change faster and give interim data in roughly 8 to 12 weeks. Accelerated data lets you move; real-time data confirms the shelf-life claim you print on the label.

    Chuffy peers into a lab stability chamber where jars sit under a thermometer, looking nervous about the heat.
    The accelerated chamber runs hot on purpose. It is trying to break the formula before a customer does.

    Is cosmetic stability testing legally required?

    Not as a specific, named protocol. Under the Modernization of Cosmetics Regulation Act (MoCRA), the responsible person for a cosmetic must ensure and keep records supporting adequate substantiation of safety. MoCRA does not mandate a particular stability test or time point. The FDA’s own guidance on product testing treats testing as the manufacturer’s responsibility and points toward independent labs for objectivity.

    So stability testing is best practice that safety substantiation strongly implies, rather than a line-item legal command for most cosmetics. Two caveats matter. First, MoCRA’s Good Manufacturing Practice rule was originally due by the end of 2025 and, as of early 2026, was still listed as a long-term action with no proposed date — check the current status before you rely on it. Second, OTC drug products — sunscreens, acne treatments, anti-dandruff shampoos — are a different world. They fall under drug GMP (21 CFR Part 211), which carries its own stability obligations. If your product makes a drug claim, the answer to “is it required?” changes to yes.

    Note also that Moe’s Group is FDA registered — a facility registration. There is no equivalent FDA sign-off for a finished cosmetic, so treat any supplier who implies one with caution.

    Chuffy holds up a thick MoCRA rulebook and looks relieved that it does not name a single test he must run.
    The law asks for substantiated safety. It does not hand Chuffy a checklist — which is its own kind of stressful.

    Who does the testing — your manufacturer or an independent lab?

    Both routes are legitimate, and the right one depends on your situation. A full-service contract manufacturer that develops your formula will usually build stability testing into development. Moe’s Group describes exactly this in its guide to skincare formulation from concept to consumer shelf: each prototype “undergoes rigorous performance and stability testing under varied conditions” to confirm the formula “maintains its integrity, color, and consistency across its shelf life,” covering microbial stability, temperature resistance and packaging compatibility. That testing sits inside its ISO 22716 (cosmetics GMP) certified quality system.

    An independent lab is the better fit in several common cases, and it is worth being honest about them:

    You already have a manufacturer and only need testing
    Microchem Laboratory is ISO 17025-accredited, FDA-registered, and explicitly markets real-time, accelerated, freeze-thaw, photostability and preservative-efficacy testing to small and mid-size personal care companies. A contract manufacturer that did not develop your formula is not the place to send a standalone testing request.
    You want third-party validation specifically
    If a retailer, investor or insurer wants an independent certificate, you need an external lab no matter who made the product. Eurofins is the large-scale, multi-test option here; expect an enterprise orientation and a quote-based process rather than a published price.
    You are pre-revenue and price-shopping one SKU
    A marketplace such as AJ Cosmo Labs connects indie founders with vetted stability labs; its published material puts a full 12-month real-time study with accelerated data at roughly $1,500–$4,500 per SKU (published June 2026). That is a sensible first step before committing to any manufacturing minimum.

    Where Moe’s Group is the wrong fit: it does not offer standalone stability testing for a formula it did not develop. If testing is genuinely all you need, use an independent lab. Moe’s is the right conversation when you want a factory to formulate, fill, label and test as one project — not when you want to buy a single test off the shelf.

    Chuffy stands at a fork in the road between a factory and an independent testing lab, holding a jar and looking undecided.
    Manufacturer or independent lab? The honest answer is: it depends on what you actually need done.

    What is different for custom (private label) versus stock (white label) formulas?

    This is where stability testing quietly changes your budget and timeline, and it maps directly onto the two routes a contract manufacturer offers.

    White label (ready-made / existing formula)
    Ready-to-go formula with a 200-unit minimum at Moe’s Group. Because the formula already exists, its stability testing has already been done. Your job is to ask for the shelf-life documentation and confirm what the baseline formula was tested against. You inherit the data; you do not pay for a new study or wait for one. This is the faster, lower-commitment route on stability as well as on price.
    Private label (custom formulation)
    A bespoke formula with a 1,000-unit minimum. A new formula means a new study. Stability testing runs during or after prototype development, before scale-up — accelerated data in roughly 8 to 12 weeks, real-time confirmation over 12 to 24 months. Build that time into your launch plan; a custom formula is not truly market-ready until its stability picture is in.
    Contract manufacturing (the service itself)
    The umbrella term for a factory making a product to a brand’s specification. Where testing, ownership and lead time land depends on the specific project rather than on the label “contract manufacturing” alone.

    The practical takeaway: if speed matters more than a signature formula, a tested white label product removes the stability wait entirely. If your point of difference is the formula, treat stability testing as a scheduled phase, not a surprise.

    Frequently asked questions

    How long does cosmetic stability testing take?

    Accelerated studies give interim data in about 8 to 12 weeks. Real-time studies run for the full claimed shelf life — commonly 12 to 24 months — and are what ultimately back up the expiry or period-after-opening you print.

    How much does it cost?

    It varies by lab, scope and number of SKUs. As one public reference point, AJ Cosmo Labs lists roughly $1,500–$4,500 per SKU for a full 12-month real-time study with accelerated data (June 2026). Labs like Eurofins quote per project rather than publishing a price.

    Does my contract manufacturer include stability testing?

    A full-service manufacturer that develops your formula usually does — ask for it in writing and ask for the resulting documentation. If you already have a formula and a manufacturer, a manufacturer will typically not test a formula it did not develop; use an independent lab instead. When in doubt, ask the factory directly what their process covers before you sign.

    Chuffy grins and holds up a stability certificate at last, standing beside a calendar showing that six months have passed since he thought he was ready to launch.
    Chuffy’s formula passed — six months after he was sure he was ready to launch. Stability testing is a phase to plan for, not a surprise to trip over.

  • Can a Cosmetic Manufacturer Make Sunscreen? What Founders Get Wrong

    No — a cosmetic manufacturer generally cannot legally make sunscreen for US commercial sale. In the United States, sunscreens are over-the-counter (OTC) drugs, so any product carrying an SPF claim must be made in a facility that holds a Drug Establishment Registration and follows pharmaceutical cGMP under 21 CFR 211. A cosmetic facility’s FDA registration — the kind Moe’s Group holds under MoCRA — covers cosmetics only and does not authorize OTC drug manufacturing. If you want to add SPF to your line, you need a different, drug-registered manufacturer.

    This trips up more founders than almost any other line-extension question. You have a skincare manufacturer you trust, your serums and moisturizers ship on time, and adding “SPF 30” to the range looks like a small next step. Legally, it is not a small step — it moves the product into a different regulatory category with a different factory behind it. Here is why, where the line actually sits, and which manufacturers do make sunscreen.

    Chuffy, the site's small round comic founder, beams as he holds up a moisturizer jar with a hand-drawn SPF 30 sticker slapped across the label.
    Chuffy has decided his moisturizer is now a sunscreen. A sticker is not a Drug Establishment Registration, but nobody has told him yet.

    Why is sunscreen a drug and not a cosmetic?

    In the US, a sunscreen is classified as an over-the-counter drug, not a cosmetic. The FDA states this plainly: because sunscreens make a claim to affect the structure or function of the body — protecting skin from UV — they are regulated as drugs (FDA: Sunscreen — How to Help Protect Your Skin).

    That classification is not cosmetic paperwork with an extra form. It changes the manufacturer’s obligations:

    • The facility must hold a Drug Establishment Registration, separate from any cosmetic facility registration.
    • Manufacturing must comply with pharmaceutical current good manufacturing practice under 21 CFR 211, not the cosmetics GMP of ISO 22716.
    • SPF claims must be substantiated by FDA-recognized SPF testing at accredited labs. Broad-spectrum claims require critical-wavelength testing to at least 370 nm; water-resistance claims require a defined 40- or 80-minute protocol.
    • The finished product carries a Drug Facts panel, not just an INCI ingredient list.
    • Active ingredients are limited to those in the OTC monograph, used within monograph concentrations — the mineral filters zinc oxide and titanium dioxide, and chemical filters such as avobenzone and octocrylene.

    The current rulebook is OTC Monograph M020 — Sunscreen Drug Products for OTC Human Use, which took effect on 9 August 2026. If a manufacturer is not set up for OTC drug production, none of the above is a bolt-on; it is a different operation.

    Chuffy buried up to his shoulders in a mountain of paperwork and folders, arms flailing, looking overwhelmed.
    The Drug Facts panel, the SPF testing file, the 21 CFR 211 batch records: sunscreen carries a different stack of paperwork than a cosmetic ever does.

    What does a cosmetic manufacturer’s FDA registration actually cover?

    This is the heart of the confusion. When a cosmetic contract manufacturer says it is “FDA registered,” that registration is a cosmetic facility registration under MoCRA — the Modernization of Cosmetics Regulation Act of 2022 (FDA: MoCRA). It tells the FDA the facility exists and makes cosmetics. It is not FDA approval, and it does not extend to drugs.

    A Drug Establishment Registration is a separate registration for facilities that make drug products, including OTC monograph drugs like sunscreen. A cosmetic facility registration cannot substitute for it, and neither can ISO 22716 stand in for 21 CFR 211. Moe’s Group, the contract manufacturer that supports this publication, describes exactly this distinction on its own certifications page: ISO 22716 vs cGMP vs FDA Registration. Its facility registration is a cosmetics registration — useful for skincare, body care and hair care, and unrelated to OTC drug manufacturing.

    So when a founder asks their cosmetic manufacturer to “just add SPF,” the honest answer from that manufacturer is usually no — not because they are being difficult, but because doing so would require a registration and a GMP regime they do not hold.

    Chuffy tangled in an absurdly long telephone cord, holding an old handset to his ear, looking exhausted.
    “Can you just add SPF to my serum?” is the call that ends with a referral to a completely different factory.

    Where is the cosmetic/drug borderline?

    The borderline sits on the claim, and it is finer than most founders expect. Consider zinc oxide, an ingredient that appears in both worlds:

    Stays a cosmetic
    A moisturizer containing zinc oxide as a skin-conditioning ingredient, with no SPF claim anywhere on the label. A cosmetic manufacturer can make this.
    Becomes an OTC drug
    The same product the moment it says “SPF 15,” “broad spectrum,” or “sun protection,” or uses zinc oxide at a monograph-recognized active concentration for that purpose. Now it needs a drug-registered manufacturer.

    A tinted moisturizer sold with no sun-protection claim is a cosmetic and can be made by a cosmetic contract manufacturer. Put “SPF 20” on that same tube and it is a drug. This is why the answer to “can my manufacturer add sunscreen?” so often hinges on one word on the label rather than the formula.

    One more trap: some SPF dosage forms are not covered by the monograph at all. SPF wipes, towelettes, shampoos and body washes fall outside the current sunscreen monograph, so even a fully drug-registered OTC manufacturer cannot make them as monograph products — they would require a new drug application.

    Chuffy sitting on the floor, one eye hugely magnified through a magnifying glass, scrutinising a long scroll labelled REGISTRATION.
    The line to check first: does the facility hold a Drug Establishment Registration, or only a cosmetic one? They are not interchangeable.

    Which manufacturers do make sunscreen?

    If SPF is on your roadmap, you need an OTC drug manufacturer. The firms below publicly describe sun-care or OTC drug manufacturing capability; all links checked 16 September 2026. We name them because a comparison that only ever points back to one company is not a comparison. Verify certifications, MOQs and lead times with each directly before you commit — those figures change, and we do not publish minimums or turnaround numbers we cannot source today.

    We have deliberately left this list without product photographs. These are contract manufacturers rather than shelf products, and we will not run stock or fabricated images of a real company’s output. Follow the links to see each firm’s own site.

    Where Moe’s Group is the wrong fit: any product carrying an SPF or broad-spectrum claim, and by the same logic other OTC-drug categories — anti-acne products with salicylic acid or benzoyl peroxide, antiperspirants, dandruff treatments. Those need a drug-registered manufacturer too. Where Moe’s Group fits well is the cosmetic side of a range: serums, moisturizers, cleansers, body and hair care, and tinted products sold without a sun-protection claim.

    White label vs private label vs contract manufacturing for SPF

    Once you are talking to an OTC drug manufacturer, the same three routes apply as for any beauty product — and the cost-and-speed order does not change just because the product is a drug. It runs white label < private label < contract manufacturing on both price and lead time.

    White label SPF
    An existing, already-tested OTC sunscreen base with your label on it. Cheapest and fastest, because the SPF testing is already done — but still made only by a drug-registered facility, and you share the formula with anyone else who white-labels it.
    Private label SPF
    Modest customization — fragrance, texture, tint — within an existing tested base, exclusive to you. More cost and more time than white label.
    Contract manufacturing SPF
    A formula built to your specification, with SPF and broad-spectrum testing run from scratch. The most expensive and slowest route, because new SPF substantiation testing is the long pole.

    The takeaway: choosing SPF does not just change the factory, it usually pushes your timeline out, because the further you move toward a custom formula, the more original testing has to happen before you can make a single claim on the label.

    Frequently asked questions

    Can any cosmetic manufacturer add sunscreen if they want to?
    Not without first obtaining a Drug Establishment Registration and meeting 21 CFR 211 pharmaceutical GMP. That is a facility-level change, not a formula tweak, which is why cosmetics-only manufacturers refer SPF work out rather than take it on.
    What is a Drug Establishment Registration?
    It is the FDA registration a facility must hold to manufacture drug products, including OTC monograph drugs such as sunscreen. It is separate from the cosmetic facility registration a skincare manufacturer holds under MoCRA.
    Is Moe’s Group set up to make OTC drugs like sunscreen?
    Based on its public certifications, Moe’s Group is registered as a cosmetic manufacturing facility and describes cosmetics GMP, not drug establishment registration or 21 CFR 211. For SPF products, a drug-registered manufacturer is the correct route; for cosmetic skincare, body and hair care, Moe’s Group is a fit.
    Does a zinc oxide moisturizer count as sunscreen?
    Only if it makes a sun-protection claim or uses zinc oxide at an active sunscreen concentration for that purpose. A zinc oxide moisturizer with no SPF claim remains a cosmetic.

    If your line is cosmetic — serums, moisturizers, cleansers, body or hair care with no SPF claim — you can talk to a cosmetic contract manufacturer such as Moe’s Group through its product inquiry form. If the product will carry an SPF claim, start instead with one of the drug-registered manufacturers above. It is the one line extension where using your existing skincare factory is not an option.

    Four Chuffys in a framed line-up: one holds a plain moisturizer looking calm, one clutches an SPF bottle looking nervous, two shrug at each other.
    The honest ending: the moisturizer stays where it is, and the SPF bottle goes to a drug facility. Two products, two factories, one much wiser Chuffy.

  • OEM vs Private Label Cosmetics: What’s the Difference?

    OEM and private label are not the same thing, even
    though manufacturers use the terms interchangeably. OEM (Original Equipment
    Manufacturing) means a factory produces to a formula you own or specify —
    it maps onto contract manufacturing, the most expensive and slowest of the three
    routes, and the one where the brand controls the formula. Private label means you
    take a formula the factory already owns and put your brand on it — cheaper
    and faster, with less control. Between them sits ODM (Original Design
    Manufacturing), where the factory develops the formula from its own library and
    licenses it to you. The single biggest source of confusion is that in Korean and
    Chinese supplier conversations, “OEM” is often used as a catch-all for any
    outsourced manufacturing, including what US buyers would call private label.

    If you have already read the difference between white label, private label and
    contract manufacturing and then received a quote from a factory that calls itself
    an “OEM/ODM manufacturer”, this is the piece that closes the gap. OEM and ODM are
    the words the rest of the world uses; white label, private label and contract
    manufacturing are how the model actually breaks down. They describe the same
    reality from two directions, and lining them up is what tells you which quote you
    are actually holding. This explains what each term means, how they map onto the
    three-tier model, which one fits your stage of growth, and where to look when none
    of them is the right answer.

    What does OEM mean in cosmetics — and why is it confusing?

    OEM stands for Original Equipment Manufacturing. In its precise
    US and EU usage, an OEM relationship is one where the factory manufactures to
    your formula or specification: you bring the recipe (or a benchmark you
    want matched, or a brief for something developed to your spec), and the factory
    makes it. In three-tier terms, that is contract manufacturing
    — the route where the brand controls the formula, and the most expensive
    and slowest of the three because the work is bespoke.

    Here is the complication that trips up almost everyone. The term “OEM” was
    borrowed from electronics and hardware, where it means something slightly
    different, and in the Asian manufacturing supply chain — particularly Korea
    and China, where a large share of the world’s cosmetics are made — “OEM” is
    frequently used as a loose catch-all for any outsourced production,
    including work a US buyer would unambiguously call private label. So a factory
    advertising “OEM services” might mean true build-to-your-spec manufacturing, or it
    might mean “we’ll put your label on our existing cream”. The word alone does not
    tell you. That ambiguity — not the definitions themselves — is the
    real reason buyers get confused, and it is why you should never accept “OEM” as an
    answer without asking the follow-up: whose formula is it, and who owns it when
    we’re done?

    Chuffy, a small round anxious sketched creature, stares up at a supplier sign reading OEM / ODM / PRIVATE LABEL with a huge question mark drawn above its head, clutching three quote sheets that all say different things.
    Three factories, three quotes, three uses of the same word. Chuffy is not, at this point, less confused than when it started.

    What does private label mean — and how does ODM sit in between?

    Private label, in the model this site uses throughout, means taking a formula
    the factory already owns — a stock or lightly modified product — and
    selling it under your brand, exclusive to you. You are not developing a recipe
    from scratch; you are branding one that exists. That makes it faster and cheaper
    than contract manufacturing, and it means the factory typically retains the
    formula unless your contract says otherwise.

    ODM — Original Design Manufacturing — is the piece most explainers
    leave out, and it is exactly the middle ground. In an ODM relationship the factory
    develops the formula from its own library or R&D and licenses it to you. You
    get something more distinctive than an off-the-shelf stock product, but the
    factory usually keeps the underlying formula IP unless you negotiate a transfer.
    In three-tier terms, ODM sits at or near private label: the
    factory owns the recipe, you own the brand on it. This is the default model behind
    a great deal of K-beauty — a Korean ODM house develops an innovative texture
    or actives system, then licenses it to many brands, each of which markets it as
    its own.

    White label
    A generic stock product sold to many retailers, with no formula modification
    and no exclusivity — your branding on an identical product competitors
    can also sell. It is the cheapest and fastest route. The
    factory owns the formula; there is no brand-specific recipe to own.
    Private label (and ODM)
    A stock or factory-developed formula made exclusive to one brand, with some
    customisation. Costs more and takes longer than white label. ODM —
    where the factory designs the formula and licenses it to you — lands
    here: the factory keeps the formula IP by default unless the
    contract transfers it. Sits in the middle on cost and lead
    time.
    Contract manufacturing (OEM, in precise usage)
    A formula developed to the brand’s own specification, with
    ownership negotiable. It is the most expensive and
    slowest     route because the work is bespoke. This is what “OEM” means
    when the term is used precisely: the factory builds to your spec, and you
    control the formula.

    The one-line map, then: white label < private label / ODM <
    contract manufacturing / OEM    , ascending on cost, on lead time and on how
    much control the brand has over the formula. What you must not do is treat “OEM”
    and “private label” as synonyms because a supplier used them that way — they
    sit at opposite ends of that ordering, and the difference is precisely who owns
    the recipe. This site’s companion piece on the
    three-tier model as the client defines it (Moe’s Group, the
    manufacturer that supports this publication) is the source of truth for that
    ordering, and nothing in the OEM/ODM vocabulary changes it.

    Chuffy stands on a set of three ascending steps labelled white label, private label / ODM, and contract manufacturing / OEM, holding a measuring tape and comparing the height of each step.
    The words changed. The staircase did not. Cost, time and control still climb in the same order.

    Which model fits which stage of brand growth?

    The right route is less about which is “best” and more about where your brand
    is, how much you can spend, and how distinctive you need the product to be. A
    rough progression that holds for most beauty brands:

    • Testing an idea, tiny budget, speed over distinctiveness:
      white label or low-MOQ private label. You are buying a licence to sell an
      existing product, the IP question is moot, and you can be on the shelf in
      weeks. The trade-off is that competitors can sell the identical formula.
    • Building a real brand, want something a little distinctive, not yet
      ready to fund formulation:       private label or ODM. You get exclusivity
      and some customisation; the factory usually keeps the formula. Good for a
      brand that needs to look and feel proprietary before it can afford to own the
      recipe.
    • Scaling, differentiation matters, you intend to own what you
      build:       contract manufacturing (true OEM). You fund development of a
      formula to your specification and negotiate ownership in the contract. It is
      the most expensive and slowest route, and the only one where owning the
      recipe is even on the table — and note “negotiable” means you must
      contract it explicitly, not assume it.

    Because that last step is where the money and the legal exposure both sit, the
    practical next move is a checklist rather than a leap. The buyer’s guide from Moe’s
    Group, how
    to choose a private label manufacturer    , is a useful one to work from whichever
    route you land on: it lists GMP certificate verification, MOQ and lead time in
    writing, what claims you can legally print, and “formulation ownership on exit
    — who owns the formula if you move” as the questions to settle before
    signing. Those questions matter as much to an ODM deal as to a full OEM one,
    because the answer changes with the model.

    Chuffy sits at a desk mapping a small product onto a growth chart that rises from a tiny sample jar to a full shelf, drawing arrows from white label up to contract manufacturing with a stubby pencil.
    Not which is best. Which is right for where the brand actually is this quarter.

    Does the factory being FDA registered mean my brand is covered?

    No — and this catches out founders who assume an OEM factory’s paperwork
    discharges their own. Under the
    Modernization of Cosmetics Regulation Act (MoCRA), the “responsible
    person” — the brand that markets the product — must register the
    facility and list each product with the FDA, keep safety-substantiation records,
    and report serious adverse events. A factory registering itself does not
    discharge the brand’s own registration obligation. If the OEM factory is FDA
    registered, you are not automatically covered; you carry your own duties as the
    responsible person, regardless of who owns the formula or where it was made.

    Keep one phrase exact, because a supplier who muddles it is often muddling
    something more important too: a cosmetics facility is FDA
    registered    , which is a filing obligation. It is never described as having
    FDA approval for its cosmetics — the FDA does not approve cosmetic products
    or the facilities that make them. Any manufacturer, OEM or private label, that
    tells you its registration means the agency has approved your product has told you
    something false, and that is a useful early filter.

    Where does Moe’s Group fit — and where doesn’t it?

    Moe’s Group is a private label and contract manufacturer in Chatsworth,
    California, formulating, filling and labelling in one facility that is FDA
    registered and ISO 22716 certified for cosmetics. In OEM/ODM language, it does both
    kinds of work — it will build from your formula (true OEM/contract
    manufacturing) or develop a concept from scratch — though it uses “private
    label and contract manufacturer” language rather than the OEM/ODM labels. Its
    specialisms are skincare, hair care and body care, including peptide-heavy work
    (copper peptides, PDRN, exosomes, tallow). That profile suits a brand building a
    skincare or body-care formula it intends to own and scale.

    Where Moe’s Group is the wrong fit — and honest alternatives
    exist. MOQs and models below change; each is a description of a manufacturing
    positioning to confirm at the source, not a stated figure:

    If you need… Better-fit alternatives Why Moe’s Group is the wrong lane
    Color cosmetics (lipstick, mascara, eyeshadow, pressed powder) Mana Products (NY), HCT Group, Intercos (Italy/US) Color is a distinct manufacturing category needing different equipment; Moe’s is a skincare / hair / body specialist.
    Micro-batch / very low MOQ (first-time founders testing demand) Innacos (Indianapolis), Lady Burd (NY), Dynamic Blending (UT) Entry-tier indie labs are built for the small-batch founder; a specialty skincare facility is structured for real volume.
    Korean ODM / K-beauty textures (sheet masks, hydrogel patches, innovation textures) Cosmax (Korea), Kolmar Korea Korean ODM houses hold proprietary texture formats and K-beauty provenance a US facility does not replicate.
    Bar soap and solid formats Twincraft (Winooski, VT) Bar soap needs specific saponification equipment; it is not Moe’s Group’s lane.
    Mass-market retail scale (large retailer private-label programs) Maesa (France/US) and other large CDMOs Big CDMOs are structured for the MOQ, audit trail and retail compliance major retail programs require.
    Pure toll manufacturing (OEM) for a formula you already own and have tested Cosmetic Solutions (Boca Raton, FL) and other ISO 22716 toll manufacturers A brand that needs manufacturing only, not formulation, may not need Moe’s Group’s development capability and may find a simpler toll manufacturer cheaper.
    OTC drug-cosmetics (SPF sunscreen, benzoyl peroxide / salicylic acid anti-acne) Contract manufacturers holding OTC drug manufacturing authorization OTC drug products are regulated under a separate framework and require a different class of facility from a cosmetics manufacturer.

    None of the entries above states a manufacturer’s MOQ or ownership terms as
    fact — directories describe manufacturing models, not the clauses in each
    factory’s standard agreement. Cross-referenced against
    IndieSource’s low-MOQ
    shortlist (checked 11 September 2026). Confirm the current minimum, price,
    certifications and, above all, the formula-ownership terms directly with each
    supplier before you commit. For neutral reference, the
    Personal Care
    Products Council     is the US trade body, and any ISO 22716 certificate a factory
    cites can be checked at
    IAF CertSearch.

    Chuffy, steadier now, ticks down a short checklist pinned to a corkboard -- whose formula, who owns it, what MOQ, which category -- crossing off items with a stubby pencil.
    Whose formula. Who owns it. What MOQ. Which category. Four questions the word ‘OEM’ never answers on its own.

    Frequently asked questions

    Is OEM the same as private label?

    No. In precise usage, OEM means the factory manufactures to a formula you own
    or specify — that maps onto contract manufacturing, where the brand controls
    the recipe. Private label means you take a formula the factory already owns and
    brand it. They sit at opposite ends of the cost, lead-time and control ordering.
    Suppliers often use the terms interchangeably, especially in Asian supply chains,
    which is the main reason buyers confuse them.

    What is ODM, and how is it different from OEM?

    ODM (Original Design Manufacturing) means the factory develops the formula from
    its own library and licenses it to you; it usually retains the formula IP unless
    you negotiate a transfer. OEM (in precise usage) means the factory builds to your
    formula or specification, with ownership negotiable. In short: with ODM the factory
    designs the recipe, with OEM you do. ODM sits near private label; OEM sits at
    contract manufacturing.

    Which is cheaper, OEM or private label?

    Private label is cheaper and faster than OEM/contract manufacturing. The order,
    ascending on both cost and lead time, is white label, then private label / ODM,
    then contract manufacturing / OEM. OEM is the most expensive and slowest because
    the formula is developed to your specification rather than taken off the shelf.

    If my OEM factory is FDA registered, is my brand covered?

    No. Under MoCRA the brand that markets the product is the “responsible person”
    and must register the facility, list each product with the FDA, keep safety
    records and report serious adverse events. A factory registering itself does not
    discharge your obligations. And “FDA registered” is a filing status, not the same
    as agency approval — the FDA does not approve cosmetics or the facilities
    that make them.

    When should I choose OEM (contract manufacturing) over private label?

    Choose OEM/contract manufacturing when differentiation matters and you intend to
    own the formula — typically when you are scaling rather than testing. It
    costs more and takes longer, and ownership is negotiable, so it must be contracted
    explicitly. Choose private label or ODM when you want speed, lower cost and
    exclusivity without funding formulation from scratch.

    Building a skincare or body-care formula you intend to own,
    rather than branding a stock product? Ask a contract manufacturer directly how it
    handles formula ownership, MOQ and lead time in writing — Moe’s Group takes
    enquiries through its
    product inquiry form.

    Chuffy, finally calm, holds a single quote sheet with the word OEM crossed out and rewritten as 'contract manufacturing -- I own the formula', nodding at a factory that is nodding back.
    Chuffy stopped arguing about the word and asked who owned the formula. The quote made sense the moment it did.

    Disclosure: Contract Beauty is published with the
    support of Moe’s Group, a contract manufacturer named in this article. We name
    competing suppliers and say where Moe’s Group is the wrong choice because a
    comparison that always concludes the same way is worth nothing. Manufacturing
    models and minimum order quantities change; confirm current terms with any
    supplier before you commit. See our
    editorial policy.

  • Who Owns the Formula in Private Label Skincare?

    In private label skincare, who legally owns the
    formula is decided by your contract, not by who paid for it. By default, the
    manufacturer that develops a formula can retain it — even if you funded
    the development. Whether that default is changed depends entirely on a written
    clause agreed before formulation starts, not after. Paying a development fee
    does not make the formula yours, and neither does signing an NDA. The right to
    own the formula, and the separate right to take production to another factory,
    each have to be spelled out in the agreement before you sign it.

    This is the question founders ask once they are past “what is private label”
    and actually evaluating a contract. It is the single most financially material
    term most of them get wrong, because the assumption is so natural: I am paying
    for it, so it must be mine. In manufacturing, that is not how ownership works.
    This piece explains what formula ownership actually means, how it differs across
    the three manufacturing routes, the contract clauses that decide the outcome,
    and where a full contract manufacturer is — and is not — the right
    partner for a brand that wants to own what it builds.

    What does “formula ownership” actually mean?

    Formula ownership is the legal title to the recipe — the specific
    ingredients, grades, percentages and process that make your product what it is.
    It is not the same as owning your brand, and it is not the same as having a
    product no one else can sell. Founders routinely conflate three separate rights,
    and the gap between them is where the money is lost:

    • Ownership is title to the formula itself — the right
      to hold, license and assign it.
    • Exclusive use means the manufacturer will not sell your
      formula to a competitor. It does not mean you own it, and it usually does
      not mean you can take it elsewhere.
    • Portability is the right to move production to a different
      factory and hand them the full formula package. This is a separate right
      again, and a formula you “own” on paper is worth little if you cannot
      lawfully obtain the documentation to make it somewhere else.

    A useful test comes from the beauty-IP guide published by
    Zicai Beauty (checked 10 September 2026): if the relationship
    ended tomorrow, could you lawfully obtain the current formula package and give
    it to a qualified replacement manufacturer? If the answer is not a clear yes in
    writing, you do not have the control you think you have — whatever the
    invoice says you paid for.

    Chuffy, a small round anxious sketched creature, hugs a beaker of its own product while a large hand labelled FORMULA gently but firmly holds the recipe card just out of reach.
    Chuffy paid for the formula. Chuffy does not, it turns out, own the formula.

    How does ownership work across the three manufacturing models?

    Formula control is another axis on which the three routes line up in a fixed
    order — the same order as cost and lead time. White label gives you
    the least control, private label sits in the middle, and contract manufacturing
    gives you the most — but “most” still is not “automatic”.     Here is
    what each route means and what happens to the formula by default:

    White label
    A generic stock product sold to many retailers, with no formula
    modification and no exclusivity — your branding on an identical
    product competitors can also sell. The factory always retains the formula,
    because there is no brand-specific formula to own. It is the
    cheapest and fastest route.
    Private label
    A stock or lightly modified formula made exclusive to one brand, with some
    customisation. The factory typically retains the formula by
    default     unless the contract states otherwise; exclusivity (no one
    else can sell the same product) is a separate negotiation from ownership.
    It sits in the middle on cost and lead time.
    Contract manufacturing
    A formula developed to your own specification, with
    ownership negotiable. It is the most expensive and
    slowest     route — and note that word “negotiable”: ownership
    is not a default deliverable here either. It has to be contracted
    explicitly, before development begins.

    That last point is the one this whole article turns on. It is tempting to
    assume that because contract manufacturing means “your own formula”, the IP
    transfers to you automatically. It does not. Moe’s Group’s own published
    position describes ownership in contract manufacturing as negotiable — an
    honest word, and the correct one. A brand that needs to own its formula should
    treat that as the opening of a negotiation to have in writing, not a box already
    ticked.

    Chuffy stands before three doors marked white label, private label and contract manufacturing, each door progressively larger, holding a key ring and looking unsure which key fits which lock.
    More control costs more and takes longer. It still does not unlock itself.

    Which contract clauses decide whether you actually own it?

    Ownership is settled in the contract language, and a handful of clauses do
    almost all of the work. Independent beauty-IP guides — including
    Made by Genie’s IP-clause breakdown (checked 10 September
    2026) and the
    NEXO Beauty Labs manufacturing guide (a contract
    manufacturer, so read it knowing it has an interest; checked 10 September 2026)
    — converge on the same short list. Get these named explicitly before you
    sign:

    • IP assignment. An explicit clause assigning ownership of
      the developed formula to the brand. This is the one that actually transfers
      title. Watch the wording: “the formula remains the property of the
      manufacturer” means the factory keeps it, and “exclusive right to use” is
      a licence, not ownership.
    • Portability. The right to obtain the full formula package
      — ingredients, grades, percentages, process — and move
      production elsewhere. Ownership without portability can leave you unable to
      make your own product anywhere but the original factory.
    • Documentation on exit. Exactly what transfers if you leave
      — the master formula, the certificates of analysis, the stability
      data. Ask what documentation you receive if you move production, because a
      formula you cannot document is a formula you cannot reproduce.
    • Exclusivity, kept separate. Whether the manufacturer can
      sell the same formula to others. This protects you from competitors using
      your product, but it is not ownership and must be negotiated on its own
      terms.
    • Termination and assignment. What happens to all of the
      above if the relationship ends, or if either company is sold. Rights that
      evaporate on termination are not rights.

    Two red flags that survive across every guide: an NDA is not an ownership
    document — it protects confidentiality, not title — and a development
    fee on the invoice does not establish ownership on its own. Only a clause does.
    This is exactly the territory the client-side guide from Moe’s Group,
    how
    to choose a private label manufacturer    , flags for buyers: it lists
    “Formulation ownership on exit — who owns the formula if you move” as one
    of the questions to ask before signing, alongside written MOQ, written lead time
    and what claims you can legally print. Because ownership is a legal question with
    real money attached — and because whether “work for hire” doctrine reaches
    a contracted formula varies by jurisdiction — get IP counsel to read the
    agreement before you sign it. Nothing in this article is legal advice.

    Chuffy sits at a desk with a magnifying glass, reading a fat contract line by line, a small stack of clauses circled in pencil beside a mug gone cold.
    The formula was never won in the lab. It was won, or lost, in clause 7.

    Where does Moe’s Group fit — and where doesn’t it?

    Moe’s Group is a private label and contract manufacturer in Chatsworth,
    California, formulating, filling and labelling in one facility that is FDA
    registered and ISO 22716 certified for cosmetics. That profile suits a brand
    building a formula it intends to own and scale — the kind of brand for
    which the ownership clauses above are worth negotiating hard. Its standard
    formula-ownership position is not published, so treat this as the question to
    ask directly, not something to assume in either direction.

    Where Moe’s Group is likely the wrong fit — and honest
    alternatives exist:

    • Brands that need automatic, non-negotiable formula transfer from
      day one.       Contract manufacturing ownership is negotiable, not a
      default. If full IP assignment is a baseline you will not move on, put that
      on the table in the first conversation and get a written answer before you
      commit — from any manufacturer, this one included.
    • Founders buying white label specifically to avoid the IP question.
      If you want to test a product before committing to formula ownership, a
      low-MOQ catalog supplier makes the IP question moot: you are buying a
      licence to sell a stock product, not a formula. That is a legitimate
      strategy, and a full contract manufacturer is over-specified for it.
    • Brands selling into the EU or UK that need the manufacturer to act
      as “Responsible Person” or supply a Cosmetic Product Safety Report.
      This is a US-based facility under a US regulatory frame; whether it
      supports EU CPNP notification or provides a CPSR as a standard deliverable
      is not something to assume — ask, and if the answer is no, a
      manufacturer inside your target market may serve you better.

    For the low-MOQ end where the IP question is moot because you are buying a
    stock licence, these suppliers publish genuinely low entry points. MOQs, prices
    and IP terms all change, so each is dated and every ownership position below is a
    question to confirm at the source, not a stated fact:

    Supplier Stated MOQ Base Formula IP position (confirm directly)
    Onoxa 12 units per SKU Florida, USA Stock catalog — you get exclusive branding on a non-exclusive formula; manufacturer retains the recipe. Confirm before signing.
    Lady Burd From 50 pieces per SKU (per directory listing) New York, USA Standard private label — manufacturer typically retains the formula. Confirm terms directly.
    Cosmetic Solutions Low MOQ on 300+ ready formulas Florida, USA Ready-made stock formulas are private label (factory retains); ask separately about custom-development ownership terms.

    MOQ figures above are as stated in independent directory listings compiled
    mid-2026 and cross-referenced with
    IndieSource’s low-MOQ
    shortlist (checked 10 September 2026). None of these describe a manufacturer’s
    legal ownership default as a fact — directories describe manufacturing
    models, not the clauses in each factory’s standard agreement. Confirm the
    current minimum, per-unit price, certifications and, above all, the ownership
    terms directly with each supplier before you commit.

    Chuffy, steadier now, works down a short checklist pinned to a corkboard -- assignment, portability, documentation, exclusivity -- crossing off items with a stubby pencil.
    Own it, move it, document it, protect it. Four boxes, ticked before signing, not after.

    Does formula ownership change your FDA and MoCRA obligations?

    No — and this is where founders get a nasty surprise. Under the
    Modernization of Cosmetics Regulation Act (MoCRA), the brand
    that markets a product is always the “responsible person”, regardless of who
    owns the formula or where it was made. The manufacturer registers its facility;
    the brand, as responsible person, must list each product with the FDA, keep
    safety-substantiation records, and report serious adverse events. Owning your
    formula does not shift those duties onto the factory, and the factory’s
    registration does not cover them for you.

    Keep one phrase straight, because a supplier who muddles it is muddling
    something more important too: a cosmetics facility is FDA
    registered    , which is a filing obligation. It is never “FDA approved” for
    its cosmetics — the FDA does not approve cosmetic products or the
    facilities that make them. Ownership of the formula and compliance
    responsibility for the finished product are two different questions, and the
    answer to the second one is: it is the brand’s, always.

    Frequently asked questions

    Does signing an NDA protect my formula?

    No. An NDA protects confidentiality — it stops the manufacturer sharing
    your information — but it does not establish ownership of the formula.
    Ownership is transferred only by an explicit IP-assignment clause in the
    manufacturing agreement. You can have a signed NDA and still not own the recipe.

    Is “exclusive use” the same as owning the formula?

    No. Exclusive use means the manufacturer will not sell your formula to a
    competitor. It does not mean you own it, and it usually does not give you the
    right to take the formula to another factory. Ownership, exclusivity and the
    right to move production are three separate rights, each negotiated on its own.

    Can I take my formula to another manufacturer?

    Only if your contract gives you both ownership (or a licence that permits it)
    and portability — the right to obtain the full formula package and have it
    made elsewhere. A formula you own on paper is not portable unless you can
    lawfully get the documentation to reproduce it. Confirm both rights before you
    sign.

    What happens to my formula if my manufacturer closes?

    That depends on your termination and assignment clauses. If they specify that
    the full formula package transfers to you on termination, you can move
    production. If they do not, you may be left without the documentation to make
    your own product. This is exactly why “documentation on exit” belongs in the
    contract, not in a hopeful conversation later.

    Does formula ownership affect my MoCRA obligations?

    No. Under MoCRA the brand that markets the product is always the “responsible
    person” — responsible for FDA product listing, safety records and
    adverse-event reporting — regardless of who owns the formula or made it.
    The manufacturer’s facility registration does not cover the brand’s separate
    obligations.

    Building a formula you intend to own rather than a catalog
    product? Ownership terms are worth settling in writing before development starts,
    so ask a contract manufacturer how it handles formula assignment, portability
    and documentation on exit — Moe’s Group takes enquiries through its
    product inquiry form.

    Chuffy, finally calm, sits on a single tidy box of its own finished product with a signed contract framed on the wall behind it, one clause circled and ticked in confident pencil.
    Chuffy read clause 7, negotiated the assignment, and got it in writing before a drop of product was made. The formula, at last, is Chuffy’s.

    Disclosure: Contract Beauty is published with the
    support of Moe’s Group, a contract manufacturer named in this article. We name
    competing suppliers and say where Moe’s Group is the wrong choice because a
    comparison that always concludes the same way is worth nothing. Nothing here is
    legal advice; have IP counsel review any manufacturing agreement before you
    sign. See our editorial policy.

  • Do cosmetic manufacturers need to register with the FDA?

    Yes. Under the Modernization of Cosmetics
    Regulation Act (MoCRA), any facility that manufactures or processes cosmetics
    for US distribution must register with the FDA, and foreign facilities are
    included. Enforcement has been live since July 1, 2024. But the obligation is
    split two ways: the factory registers its facility once, and the brand —
    the “responsible person” whose name is on the label —
    separately lists every product it markets. Neither party can file for the
    other. If your average US cosmetics sales stay under $1 million over three
    years, the small business exemption may excuse you from both, with narrow
    exceptions.

    This is the question every first-time beauty founder asks a contract
    manufacturer, usually phrased as “do you have FDA approval?” The
    honest answer is more useful than a yes: no cosmetics manufacturer holds FDA
    approval, because the FDA does not approve cosmetics or the factories that make
    them. What exists is
    registration — an administrative record — and it lands on two
    different desks. Get that distinction wrong and you either overpay a compliance
    consultant for work you did not need, or you skip a filing that was legally
    yours to make.

    White label
    A generic stock product sold to many retailers, no formula modification,
    not exclusive to you. Cheapest and fastest. The supplier’s facility is
    usually already registered; you are buying a finished product.
    Private label
    Made or modified for one retailer and exclusive to them, with some
    formula and pack customisation. Costs more and takes longer than white
    label.
    Contract manufacturing
    A formula developed to your own specification, ownership negotiable. Most
    expensive and slowest — and the route where you most need to confirm
    the specific facility’s registration status yourself.

    On cost, on lead time and on how much control you hold, the order is
    constant: white label sits below private label, which sits below contract
    manufacturing. That ordering also tracks how much of the FDA paperwork becomes
    your problem. Buy a white-label product off a catalogue and the supplier’s
    registration is already handled; commission a bespoke formula and you should
    ask, in writing, for the manufacturing facility’s registration status before
    you list your product.

    Chuffy, a small round anxious creature drawn in loose pencil, squints at a government form labelled FDA and scratches his head.
    Chuffy discovers the form is not the one-and-done he was
    promised.

    What does MoCRA actually require from a cosmetic manufacturer?

    MoCRA, passed in December 2022, is the first major update to US cosmetics law
    since 1938. Its two headline obligations are facility registration and product
    listing. A facility that manufactures or processes cosmetics distributed in the
    US must register with the FDA and renew that registration every two years from
    its initial registration date. Registration is submitted through the FDA’s
    Cosmetics Direct portal and produces
    an establishment identifier (an FEI number) for the facility.

    Registration is not a seal of quality. It puts the facility on record and
    gives the FDA a suspension power if a product is later found to pose a serious
    health risk. It says nothing about whether the formulas made there are good, or
    whether the plant follows any particular manufacturing standard. That is the
    gap most founders misread.

    Chuffy holds up a certificate hopefully, imagining a gold seal, while a plain rubber stamp reading ON RECORD hovers behind him.
    Registration is a record, not a rosette. Chuffy takes it
    personally.

    Does FDA registration mean the manufacturer has FDA approval?

    No. This is the single most common misunderstanding in the category, and it
    is worth stating plainly: the FDA does not approve cosmetics, cosmetic
    ingredients (other than colour additives), or the facilities that make
    them.     There is no FDA approval for a skincare factory to hold in the
    first place. A manufacturer that claims to have FDA approval is either mistaken
    about the law or hoping you are.

    Registration is an administrative filing. It does not validate a formula, a
    safety file or a quality system. So when you compare suppliers, treat
    “registered” as a floor, not a differentiator — it is the
    baseline every compliant US facility clears. Moe’s Group, for instance, is an
    FDA-registered contract manufacturer, and its own team has published a
    plain-English breakdown of
    what ISO 22716, cGMP and FDA registration each
    actually mean     and how to tell them apart. That distinction — one is
    audited, one is expected, one is merely filed — is the part worth reading
    before you sign anything.

    The forward-looking wrinkle: MoCRA directs the FDA to write mandatory Good
    Manufacturing Practice (GMP) rules for cosmetics, but as of mid-2026 the agency
    has moved that rulemaking to its
    long-term actions list, with no
    proposed rule expected within the next twelve months. So there is not yet a
    legally binding federal GMP standard. In the meantime, ISO 22716 — the
    international GMP standard for cosmetics — is the de facto proxy buyers use.
    Verify any ISO 22716 certificate independently through
    IAF CertSearch rather than trusting a manufacturer’s own
    page.

    Chuffy stands between two office doors, one marked FACTORY and one marked BRAND, holding two separate forms and looking from one door to the other.
    Two doors, two filings. Chuffy realises he cannot post both
    letters through the same slot.

    Who files — the factory or the brand?

    Both, but different things. The facility registration is filed by the
    manufacturer or processor (or by the responsible person on the factory’s behalf
    if both agree). The product listing is filed by the “responsible
    person” — the manufacturer, packer or distributor whose name appears
    on the product label. For most launches that is the brand, not the factory.

    The practical consequence is the one a lot of founders miss: a contract
    manufacturer registers its facility once, and that single registration covers
    every brand it produces for. It does not list your products for you.
    You, as the responsible person, must list each product you market, referencing
    the manufacturing facility’s FEI number. A factory that promises to
    “handle all your FDA compliance” is describing something narrower
    than it sounds. Some full-service manufacturers offer listing support as a paid
    service — if that matters to you, ask the specific question and get the
    answer in writing rather than assuming.

    Does the small business exemption apply to my brand?

    Possibly, and it is worth checking before you spend money. Facilities and
    responsible persons whose average gross annual US cosmetics sales are under
    $1 million over the previous three-year period are exempt
    from the facility registration and product listing requirements. A brand doing
    a first run of 500 units at a $25 retail price is turning over roughly $12,500
    — comfortably under the threshold.

    The exemption has hard exceptions. It does not apply to products that
    regularly contact the mucous membrane of the eye, products that are injected,
    products intended for internal use, or products meant to alter appearance for
    more than 24 hours without consumer-initiated removal (semi-permanent makeup and
    some hair dyes). If you are launching anything in those categories, the size of
    your business does not get you out of registering. Confirm your own position
    against the FDA’s own
    registration and listing page
    rather than a manufacturer’s summary of it.

    Chuffy points proudly at a tiny sales chart barely above the floor, standing next to a sign reading UNDER $1M, looking relieved.
    For once, being small pays off. Chuffy has never been so pleased
    about a modest sales chart.

    What about foreign manufacturers — and where is a US factory the wrong fit?

    MoCRA applies to foreign facilities that manufacture cosmetics for the US
    market exactly as it applies to domestic ones: they register, they designate a
    US Agent, and the brand still files the product listings. Geography is not a
    compliance shortcut. A Korean or Chinese factory can be the right call when you
    are already at scale and want formulation expertise a general US manufacturer
    cannot match — certain K-beauty textures and fermented actives, for
    instance.

    Being honest about fit is the whole point of this site, so here is where a
    US cosmetics contract manufacturer — Moe’s Group included — is the
    wrong answer:

    • Your products are OTC drugs. SPF sunscreens, salicylic
      acid acne washes and dandruff treatments are regulated as over-the-counter
      drugs, not cosmetics. They fall under drug establishment registration, a
      separate system MoCRA cosmetics registration does not cover. A cosmetics
      facility’s registration does not substitute. If your hero product is an OTC
      drug, you need a manufacturer set up for that pathway.
    • You will stay under the $1M exemption. If you are testing
      a market with a small first run, a white-label catalogue supplier who is
      already registered and compliant may be the sensible starting point —
      cheaper, faster, and no bespoke tooling to justify.
    • You want the factory to own your product listing. It
      legally cannot. If you would rather not touch the paperwork at all, that is a
      reason to budget for a regulatory consultant, not to expect the plant to
      absorb a filing the law assigns to you.

    When you do want US-based bespoke manufacturing, these are real alternatives
    worth putting on a shortlist alongside each other. Verify each one’s current
    registration status yourself at
    FDA Cosmetics Direct on the day you
    shortlist — status and details change, and we do not reprint FEI numbers
    that could be stale.

    Manufacturer Location Often cited for
    Cosmetic Solutions Boca Raton, FL Clinical-grade
    custom and private label, clean-beauty positioning
    Dynamic Blending Vineyard, UT Indie and emerging
    brands, lower entry MOQs (confirm current MOQ directly)
    Kolmar USA Olyphant, PA Prestige and OTC-capable
    lines at mid-to-large scale — relevant if you have a drug crossover
    product
    Voyant Beauty IL / IN / NJ Enterprise-scale
    haircare and skincare; usually too large for an early-stage brand

    How do I verify that my manufacturer is actually registered?

    Do not take a logo or a line on a sales deck as proof. Ask the manufacturer
    for their facility’s registration status and, if you want independent
    confirmation, check through
    FDA Cosmetics Direct. For their
    quality standard, verify any ISO 22716 certificate at
    IAF CertSearch rather than on the manufacturer’s own site.
    And read the FDA’s
    MoCRA overview once yourself —
    it is short, and it is the source everything else is paraphrasing.

    Frequently asked questions

    Is an FDA-registered cosmetic manufacturer safer than an
    unregistered one?     Registration is a legal requirement, not a safety
    grade. It puts a facility on record; it does not audit the product. Use the
    manufacturer’s quality standard (ISO 22716) and your own due diligence to judge
    quality.

    Do I need to register if I only sell online? Yes, if your
    product is distributed in the US and you are not under the small business
    exemption. Channel does not change the obligation; sales volume and product type
    do.

    Can my contract manufacturer list my products for me? Only
    if they explicitly offer it as a service — and even then, legal
    responsibility for the listing sits with you as the responsible person. Ask
    directly and get it in writing.

    Does registration expire? Facility registration renews every
    two years from the initial registration date. Product listings are updated
    annually. Missing a renewal is not something you want to discover during a
    retail onboarding.

    What if my product is a sunscreen or acne treatment? Those
    are OTC drugs, not cosmetics, and MoCRA’s cosmetics registration does not cover
    them. You need a manufacturer registered for drug establishment purposes and a
    different compliance conversation entirely.

    Chuffy, now calm and slightly smug, sits on top of a neat stack of two filed forms holding a mug that reads RESPONSIBLE PERSON.
    Two filings, two desks, one slightly smug founder. Chuffy has
    finally read the whole form.

  • Does your cosmetic contract manufacturer need to be local?

    Location matters for the working relationship, not
    for regulatory compliance. Under the Modernization of Cosmetics Regulation Act
    (MoCRA), a factory in Florida and a factory in South Korea are both required to
    register with the FDA, so proximity buys you no legal or safety advantage. What
    distance actually changes is how easily you can visit for sampling sessions, how
    many time zones sit between you and your factory, and whether freight is a real
    line in your unit economics. For most brands with a clear brief and a
    remote-friendly way of working, location ranks well below minimum order
    quantity, certifications and category fit as a selection criterion.

    “Cosmetic contract manufacturers near me” is one of the most common searches a
    new beauty founder runs, and the instinct behind it is reasonable: a factory you
    can drive to feels safer, more accountable, easier to trust. Some of that
    instinct is right and some of it is a myth that can cost you the best supplier
    for your product. This guide separates the two — where being local genuinely
    helps, where it makes no difference at all, and how to think about the trade
    before you narrow your shortlist by zip code.

    White label
    A generic stock product sold to many retailers with no formula change and
    no exclusivity. It is the cheapest and fastest route, with
    the lowest brand control — you and a competitor can sell the identical
    product.
    Private label
    A stock or lightly modified formula made exclusive to one brand. It sits in
    the middle on cost, lead time and control.
    Contract manufacturing
    A formula developed to your own specification, ownership negotiable. It is
    the most expensive and slowest route, and gives the brand
    the most control over the product.

    The order is fixed: white label, then private label, then contract
    manufacturing    , on cost, on lead time and on how much of the product is
    truly yours. It matters here because a “near me” search will surface all three
    kinds of supplier side by side, and a local white-label catalog is not the same
    offer as a local contract manufacturer even if both are ten minutes away.

    Chuffy, a small round anxious sketched creature, stands on a paper map with a magnifying glass, peering at factory pins scattered across the whole country instead of just the one nearest to it.
    Chuffy assumed the nearest factory was the right factory. The map had other ideas.

    What is the “near me” search really asking?

    Strip away the map and a “near me” search is three separate anxieties wearing
    one coat:

    • Can I visit? Some founders want to stand on the filling
      line, smell the batch, and sign off a sample in person. That is a real and
      legitimate need for certain products and certain people.
    • Will shipping eat my margin? A pallet of finished product
      has to travel from the factory to your fulfillment center. The further it
      travels, the more freight costs, at least in theory.
    • Do time zones make this harder? A factory five hours ahead
      answers your email overnight; a factory eight hours behind means every
      question loses a day.

    Notice what is not on that list: compliance. Founders often assume a
    local factory is a more legitimate one. It is the single most common
    misconception about sourcing, and it is wrong — which is where the next section
    comes in.

    Chuffy holds two identical certificates side by side, one stamped with a US flag and one with a Korean flag, looking baffled that they say exactly the same thing.
    Same rulebook, different flags. That was the part Chuffy did not expect.

    Does a local manufacturer mean better FDA compliance?

    No. This is the myth worth killing first. Under
    MoCRA, any facility that manufactures or processes cosmetics
    for the US market must register with the FDA, whether it sits in Ohio or Osaka.
    Enforcement of facility registration began in mid-2024, and registrations renew
    on a two-year cycle. A foreign facility must additionally designate a US Agent as
    the FDA’s point of contact — an extra step for the factory, not a lower bar.

    So the regulatory threshold is registration — and, once the
    FDA finalizes its Good Manufacturing Practice rule, GMP compliance — not
    geography. A registered manufacturer in Florida and a registered manufacturer in
    South Korea are equally compliant on that axis. The law-firm analyses tracking
    MoCRA’s rollout, such as
    Foley & Lardner’s 2026 briefing, make the same point:
    oversight follows the registration, not the address.

    Two practical consequences follow:

    • Do not treat “US-based” as a compliance checkbox. It tells
      you nothing about whether a specific factory is registered. Verify the
      factory, not the country.
    • Check the certification, not the flag. The cosmetics GMP
      standard is ISO 22716. Do not take a manufacturer’s word that it holds one —
      look the certificate up on the accreditation body’s own register at
      IAF CertSearch.
      A genuine certificate is searchable there regardless of where the factory
      is.

    One more caution that cuts across geography: the FDA does not approve cosmetics
    or the facilities that make them. The legal step is registration, and approval
    simply does not exist for a cosmetic product. So any supplier, local or overseas,
    that claims the FDA has approved it is misrepresenting the law, and that is a red
    flag about the supplier rather than a mark in its favor.

    Chuffy sits at a small desk with a video call on one screen and a calendar of flights on the other, weighing a plane ticket against a webcam with a thoughtful frown.
    A flight, or a video call and a courier. Chuffy realizes it depends entirely on the product.

    When does location genuinely matter?

    Distance stops being neutral in a handful of specific situations. If any of
    these describe you, weight geography heavily:

    • You need frequent in-person sampling. Fragrance,
      color-matching and texture are hard to judge over a courier. If your
      development process needs you physically in the room monthly or more, a
      factory a short drive away removes real friction that a distant one cannot.
    • Freight is a meaningful share of your unit cost. For heavy,
      bulky or low-margin products, shipping a full production run across an ocean
      can move the math. For a light, high-margin serum it rarely does — but run
      your own numbers rather than assuming.
    • Your working style is synchronous. If you need same-day
      back-and-forth during development, a large time-zone gap slows every
      decision. Some teams thrive on overnight hand-offs; others lose weeks to
      them. Know which you are.

    Geography also matters in reverse: some categories are simply better
    sourced far from home, which is the point the next section makes.

    Chuffy, calmer now, ticks items off a short shortlist pinned to a board — MOQ, certifications, category, and, near the bottom, a small circle around the word 'location'.
    Location made the shortlist. It just did not make the top of it.

    When does location not matter — and when should you look overseas?

    For most launches, a clear written brief, video walkthroughs of the line, and
    couriered samples close the distance well enough that geography drops below MOQ,
    certifications and category fit. And for some products, the strongest supplier is
    deliberately not local:

    • K-beauty formulations. Sheet masks, fermented actives and
      certain advanced textures are genuinely better sourced from Korean
      manufacturers with native expertise in them — a technical advantage, not
      just a cost play. Englewood Lab in New Jersey is a US option with Korean
      formulation roots if you want the expertise closer to home.
    • Scale at low cost. Large Chinese facilities can win on
      price once your volumes are high enough to manage quality control rigorously
      from a distance. That “if” is doing real work — QC discipline matters more
      the further away the factory is.

    Whichever route you pick, remember the MoCRA point: an overseas factory is not
    a compliance downgrade. It just needs to be registered and to have designated a
    US Agent, and it comes with longer lead times and more sampling friction to plan
    around.

    US contract manufacturers by region — and where does Moe’s Group fit?

    If proximity does matter for your product, it helps to know the map. Below is a
    starting shortlist of US manufacturers by region. Minimum order
    quantities change constantly and vary by product and route — treat every figure
    as a prompt to ask, not a quote, and confirm it with the factory before you plan
    around it.     For a fuller regional rundown, Moe’s Group publishes its own
    roundup of US skincare manufacturers by region — useful as a
    map, with the honest caveat that Moe’s Group is on the list it wrote.

    Manufacturer Region Best fit
    Cosmetic Solutions Boca Raton, FL (East Coast) Clinical-grade private label and custom for growth-stage brands
    Dynamic Blending Vineyard, UT (Mountain West) Indie and emerging brands wanting a lower-entry custom path
    Mana Products New York, NY (Northeast) Prestige color cosmetics plus full-service skincare
    RainShadow Labs St. Helens, OR (Pacific Northwest) Organic and natural formulas, flexible lower-volume options
    Moe’s Group Chatsworth, CA (West Coast) Private label and contract manufacturing for skincare, hair and body care

    Manufacturer sites checked 1 September 2026; regions from each company’s own
    listings. Moe’s Group is a private label and contract manufacturer in Chatsworth,
    California, and it is FDA registered — a facility filing obligation, which is a
    different thing from approval, since approval does not exist for cosmetics.

    Where Moe’s Group is the wrong fit:

    • You are on the East Coast and need frequent in-person visits.
      California is a coast-to-coast flight and a three-hour time-zone gap. If your
      process depends on being in the building monthly or more, a factory in FL,
      PA, NJ or NY removes travel that a West Coast one cannot.
    • Very small first orders. If you want a handful of units of a
      stock formula just to test demand, a contract manufacturer is over-specified.
      A low- or no-minimum white label catalog supplier such as
      Selfnamed
      — which is a catalog white-label service, not a contract manufacturer — is
      the honest first step.
    • Color cosmetics. Moe’s Group focuses on skincare, hair care
      and body care. If you need lipstick, eyeshadow or pressed powder, a
      color-capable house such as Mana Products fits better.
    • OTC drug categories. Sunscreen (SPF), acne treatments and
      dandruff shampoo are regulated as over-the-counter drugs, not cosmetics, and
      need a manufacturer operating under the OTC drug framework — regardless of how
      near it is to you.
    • Native K-beauty formulation. For sheet masks and certain
      fermented or advanced-texture products, a Korean manufacturer’s native
      expertise can beat any US option on the formulation itself.

    Naming those cases is the point of an honest comparison: the best factory is the
    one that fits your product, your order size and your working style — and sometimes
    that is not the nearest one, and sometimes it is not Moe’s Group.

    Frequently asked questions

    Are local cosmetic manufacturers more FDA compliant?

    No. Under MoCRA, any facility making cosmetics for the US market must register
    with the FDA whether it is domestic or foreign, and foreign facilities also
    designate a US Agent. Compliance follows the registration, not the location.
    Verify the specific factory rather than assuming its country makes it safe.

    Does a nearby manufacturer save on shipping?

    Sometimes. For heavy, bulky or low-margin products, freight from a distant
    factory can be a real cost. For light, high-margin items it usually is not. Run
    your own unit-economics numbers rather than assuming proximity always wins.

    When is it worth using an overseas manufacturer?

    When the expertise or economics genuinely favor it: Korean manufacturers for
    K-beauty formulations, or large overseas facilities for cost at scale if you can
    manage quality control from a distance. An overseas factory still has to be
    FDA-registered, so it is not a compliance downgrade — just a longer, more
    sampling-heavy relationship.

    How do I verify a manufacturer’s certifications from far away?

    Look the certificate up on the accreditation body’s own register — the cosmetics
    GMP standard is ISO 22716, and accredited certificates are searchable at IAF
    CertSearch. Do not rely on a logo on the manufacturer’s own website, wherever the
    factory is located.

    What matters more than location when choosing a manufacturer?

    Minimum order quantity, the right certifications, and category fit — whether the
    factory actually makes your kind of product under the right regulatory framework.
    For most brands, location ranks below all three.

    Deciding whether geography should shape your shortlist? If you
    want a private label or contract manufacturer for skincare, hair or body care and
    distance is not a dealbreaker, Moe’s Group takes enquiries through its
    product inquiry
    form    .

    Chuffy, finally relaxed, sits at home in slippers on a video call with a faraway factory on the screen, a neat box of its own finished product on the desk and a coffee in hand.
    Chuffy never did visit the factory. The product turned out fine anyway.

    Disclosure: Contract Beauty is published with the
    support of Moe’s Group, a contract manufacturer named in this article. We name
    competing suppliers and say where Moe’s Group is the wrong choice because a
    comparison that always concludes the same way is worth nothing. See our
    editorial policy.